# AFATINIB
> **ANDA210804** · Abbreviated New Drug Application (Generic) · Sponsor: MSN PHARMACEUTICALS INC · Approved 2026-02-18
## Drug
- **FDA Application Number:** ANDA210804
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AFATINIB
- **Generic name:** Afatinib
- **Active ingredients:** AFATINIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MSN PHARMACEUTICALS INC
- **First approval:** 2026-02-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210804)
---
*MORVS · CC0 1.0*